Fate Therapeutics
FATE
FATE
140 hedge funds and large institutions have $101M invested in Fate Therapeutics in 2025 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 38 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 137 → 140 (+3)
0.38% more ownership
Funds ownership: 69.42% → 69.8% (+0.38%)
Holders
140
Holding in Top 10
1
Calls
$112K
Puts
$49K
Top Buyers
| 1 | +$10.7M | |
| 2 | +$1.32M | |
| 3 | +$847K | |
| 4 |
Two Sigma Advisers
New York
|
+$648K |
| 5 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
+$483K |
Top Sellers
| 1 | -$4.69M | |
| 2 | -$2.78M | |
| 3 | -$2.39M | |
| 4 |
Morgan Stanley
New York
|
-$1.89M |
| 5 |
Goldman Sachs
New York
|
-$1.29M |
